Medazepam

Medazepam
Clinical data
Trade names	Rudotel
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	N05BA03 (WHO) ;
Legal status
Legal status	BR: Class B1 (Psychoactive drugs); CA: Schedule IV; DE: Prescription only (Anlage III for higher doses); US: Schedule IV;
Pharmacokinetic data
Bioavailability	50–75% (Сmax = 1–2 hours)
Protein binding	>99%
Metabolism	Hepatic
Elimination half-life	2 hours, 36–150 hours (terminal)
Excretion	Renal (63–85%), Biliary 15–37%
Identifiers
	IUPAC name 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine;
CAS Number	2898-12-6 ;
PubChem CID	4041;
DrugBank	none ;
ChemSpider	3901 ;
UNII	P0J3387W3S;
KEGG	D01292 ;
ChEMBL	ChEMBL28333 ;
CompTox Dashboard (EPA)	DTXSID1048708 ;
ECHA InfoCard	100.018.895
Chemical and physical data
Formula	C16H15ClN2
Molar mass	270.76 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES ClC1=CC(C(C2=CC=CC=C2)=NCCN3C)=C3C=C1;
	InChI InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3 ; Key:YLCXGBZIZBEVPZ-UHFFFAOYSA-N ;
	(what is this?) (verify)

Medazepam is a drug that is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It is known by the following brand names: Azepamid, Nobrium, Tranquirax (mixed with bevonium), Rudotel, Raporan, Ansilan and Mezapam. Medazepam is a long-acting benzodiazepine drug. The half-life of medazepam is 36–200 hours.